Factors of impaired health-related quality of life in patients with precapillary pulmonary hypertension

被引:0
|
作者
Stefanidou, Aristoula [1 ]
Kosmidis, Diamantis [2 ]
Arvanitaki, Alexandra [2 ]
Panagiotidou, Evangelia [3 ,5 ]
Mouratoglou, Sofia-Anastasia [2 ]
Boutou, Afroditi [4 ]
Giannakoulas, George [2 ]
Karvounis, Haralambos [2 ]
Ziakas, Antonios [2 ]
Stanopoulos, Ioannis [3 ]
Pitsiou, Georgia [3 ]
机构
[1] Aristotle Univ Thessaloniki, Gen Hosp Thessaloniki G Papanikolaou, Cardiol Dept, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, AHEPA Gen Univ Hosp, Dept Cardiol 1, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Gen Hosp Thessaloniki G Papanikolaou, Resp Failure Clin, Thessaloniki, Greece
[4] Thessaloniki Univ, Hippokrat Gen Hosp, Dept Resp Med, Sch Med, Thessaloniki, Greece
[5] Aristotle Univ Thessalonik, Resp Failure Clin, Gen Hosp Thessaloniki G Papanikolaou, Nikolaou Plastira St 24, Thessaloniki 54250, Greece
关键词
health-related quality of life pulmonary; hypertension SF-36 survey Minnesota living; with pulmonary hypertension questionnaire; LUNG-DISEASE; VALIDATION;
D O I
10.18332/pne/178465
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
INTRODUCTION Pulmonary hypertension (PH) is related to a variety of symptoms like dyspnea at rest, fatigue and exercise intolerance, all of which have a detrimental influence on patients' quality of life (QOL). Disease-specific health-related QOL (HRQOL) questionnaires are useful tools to objectively estimate the functional and psychological status of PH patients. The purpose of this study was to identify potential factors affecting physical and mental HRQOL in patients with precapillary PH. METHODS We conducted a prospective cross-sectional analysis of HRQOL questionnaires in individuals with precapillary PH (PH-Groups 1, 3, or 4) using the Short form 36-item health survey (SF-36) and the Minnesota living with pulmonary hypertension questionnaire (MLHF-PH). Between January and February 2019, 73 consecutive patients, being followed up in two Greek PH centers, being clinically stable at the last three months and receiving PHspecific therapies based on the European PH Guidelines, completed both questionnaires. RESULTS Patients with PH due to lung disease (PH-Group 3) presented significantly worse scores on MLHF-PH and significantly reduced scores in SF36 'physical functioning' and 'role physical' compared to the other PH-Groups. These patients were more frequently under oxygen therapy (p<0.001) and had a more advanced WHO FC (p=0.01). Oxygen treatment, WHO FC, 6MWD, and hemodynamic variables were also strongly associated with HRQOL. Patients receiving triple combination PH-therapy reported lower HRQOL scores. CONCLUSIONS Patients with precapillary PH had impaired QOL. Those with PH due to lung disease reported the worst scores in HRQOL instruments. Several clinical, functional and hemodynamic factors were associated with reduced QOL.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Health-related quality of life in cardiac patients with dyslipidemia and hypertension
    Lyne Lalonde
    Annette O'Connor
    Lawrence Joseph
    Steven A. Grover
    Quality of Life Research, 2004, 13 : 793 - 804
  • [42] Health-related quality of life and associated factors in patients with chronic obstructive pulmonary disease
    Amit M. Shah
    Rima B. Shah
    Shruti Kachoria
    Drugs & Therapy Perspectives, 2019, 35 : 241 - 249
  • [43] Health-related quality of life and associated factors in patients with chronic obstructive pulmonary disease
    Shah, Amit M.
    Shah, Rima B.
    Kachoria, Shruti
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (05) : 241 - 249
  • [44] Health-related quality of life in cardiac patients with dyslipidemia and hypertension
    Lalonde, L
    O'Connor, A
    Joseph, L
    Grover, SA
    QUALITY OF LIFE RESEARCH, 2004, 13 (04) : 793 - 804
  • [45] Factors related to the quality of life in patients with pulmonary arterial hypertension
    Sarzynska, K.
    Polanski, J.
    Kopec, G.
    Mroczek, E.
    Jankowska-Polanska, B.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2021, 20 : 111 - 111
  • [46] Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
    Ghofrani, Hossein-Ardeschir
    Galie, Nazzareno
    Grimminger, Friedrich
    Humbert, Marc
    Keogh, Anne M.
    Rubin, Lewis J.
    Sikirica, Mirko
    Fritsch, Arno
    Davie, Neil
    Hudgens, Stacie
    Bonner, Nicola
    Luong, Ba
    Langleben, David
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [47] Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension
    Zlupko, Michael
    Harhay, Michael O.
    Gallop, Robert
    Shin, Jennifer
    Archer-Chicko, Chris
    Patel, Rajesh
    Palevsky, Harold I.
    Taichman, Darren B.
    RESPIRATORY MEDICINE, 2008, 102 (10) : 1431 - 1438
  • [48] Impact of sildenafil citrate on health-related quality of life in patients with pulmonary arterial hypertension (PAH)
    Pepke-Zaba, J.
    Brown, M.
    Parpia, T.
    Gilbert, C.
    Burgess, G.
    EUROPEAN HEART JOURNAL, 2005, 26 : 643 - 643
  • [49] Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis
    Yount, Susan E.
    Beaumont, Jennifer L.
    Chen, Shih-Yin
    Kaiser, Karen
    Wortman, Katy
    Van Brunt, David L.
    Swigris, Jeffrey
    Cella, David
    LUNG, 2016, 194 (02) : 227 - 234
  • [50] Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis
    Susan E. Yount
    Jennifer L. Beaumont
    Shih-Yin Chen
    Karen Kaiser
    Katy Wortman
    David L. Van Brunt
    Jeffrey Swigris
    David Cella
    Lung, 2016, 194 : 227 - 234